EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

A complex cyclical One Health pathway drives the emergence and dissemination of antimicrobial resistance

Elizabeth M Parker, Gregory A Ballash, Dixie F Mollenkopf, Thomas E Wittum

American Journal of Veterinary Research · 2024

DOI: 10.2460/ajvr.24.01.0014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Veterinary Research, 2024. Verfasst von Elizabeth M Parker und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: One Health, Anti-Infective Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since their commercialization, scientists have known that antimicrobial use kills or inhibits susceptible bacteria while allowing resistant bacteria to survive and expand. Today there is widespread antimicrobial resistance (AMR), even to antimicrobials of last resort such as the carbapenems, which are reserved for use in life-threatening infections. It is often convenient to assign responsibility for this global health crisis to the users and prescribers of antimicrobials. However, we know that animals never treated with antimicrobials carry clinically relevant AMR bacteria and genes. The causal pathway from bacterial susceptibility to resistance is not simple, and dissemination is cyclical rather than linear. Amplification of AMR occurs in healthcare environments and on farms where frequent exposure to antimicrobials selects for resistant bacterial populations. The recipients of antimicrobial therapy release antimicrobial residues, resistant bacteria, and resistance genes in waste products. These are reduced but not removed during wastewater and manure treatment and enter surface waters, soils, recreational parks, wildlife, and fields where animals graze and crops are grown for human and animal consumption. The cycle is complete when a patient carrying AMR bacteria is treated with antimicrobials that amplify the resistant bacterial populations. Reducing the development and spread of AMR requires a One Health approach with the combined commitment of governments, medical and veterinary professionals, agricultural industries, food and feed processors, and environmental scientists. In this review and in the companion Currents in One Health by Ballash et al, JAVMA , April 2024, we highlight just a few of the steps of the complex cyclical causal pathway that leads to the amplification, dissemination, and maintenance of AMR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

One HealthAnti-Infective AgentsHumansAnimalsAnti-Bacterial AgentsDrug Resistance, BacterialAnimals, WildBacteria

Stichwörter der Autor:innen

One Healthantimicrobial resistanceenvironmenthealthcarewastewater

Substanzen

Anti-Bacterial AgentsAnti-Infective Agents

Zitieren

APA

Parker, E. M., Ballash, G. A., Mollenkopf, D. F., & Wittum, T. E. (2024). A complex cyclical One Health pathway drives the emergence and dissemination of antimicrobial resistance. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.24.01.0014

Vancouver

Parker EM, Ballash GA, Mollenkopf DF, Wittum TE. A complex cyclical One Health pathway drives the emergence and dissemination of antimicrobial resistance. American Journal of Veterinary Research. 2024. doi:10.2460/ajvr.24.01.0014

BibTeX
@article{Parker2024,
  author = {Parker, Elizabeth M and Ballash, Gregory A and Mollenkopf, Dixie F and Wittum, Thomas E},
  title = {A complex cyclical One Health pathway drives the emergence and dissemination of antimicrobial resistance},
  journal = {American Journal of Veterinary Research},
  year = {2024},
  doi = {10.2460/ajvr.24.01.0014}
}
Kostenlos starten →